Table of Contents

company-logo

Acticor Biotech SAS operates as a clinical stage biotechnology company that develops drugs for the treatment of acute phase of thrombotic diseases. The company develops glenzocimab, a humanized monoclonal antibody fragment that targets a specific platelet glycoprotein. It is also involved in two clinical programs in Phase II/III registration for the treatment of ischemic stroke; and two other Phase II trials addressing major cardiovascular emergencies with clinical results expected in ischemic stroke and Covid-19 respiratory distress syndrome. The company was incorporated in 2013 and is headquartered in Paris, France.

Acticor BiotechS Dividend Announcement

• Acticor BiotechS does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Acticor BiotechS dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Acticor BiotechS Dividend History

Acticor BiotechS Dividend Yield

Acticor BiotechS current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Acticor BiotechS stock? Use our calculator to estimate your expected dividend yield:

Acticor BiotechS Financial Ratios

P/E ratio-0.25
PEG ratio0.00
P/B ratio-0.81
ROE447.51%
Payout ratio0.00%
Current ratio0.85
Quick ratio0.85
Cash Ratio0.42

Acticor BiotechS Dividend FAQ

Does Acticor BiotechS stock pay dividends?
Acticor BiotechS does not currently pay dividends to its shareholders.
Has Acticor BiotechS ever paid a dividend?
No, Acticor BiotechS has no a history of paying dividends to its shareholders. Acticor BiotechS is not known for its dividend payments.
Why doesn't Acticor BiotechS pay dividends?
There are several potential reasons why Acticor BiotechS would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Acticor BiotechS ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Acticor BiotechS has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Acticor BiotechS a dividend aristocrat?
Acticor BiotechS is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Acticor BiotechS a dividend king?
Acticor BiotechS is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Acticor BiotechS a dividend stock?
No, Acticor BiotechS is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Acticor BiotechS stocks?
To buy Acticor BiotechS you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Acticor BiotechS stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.